Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients.

Chingching FoocharoenPritaporn KingkaewYot TeerawattananonAjanee MahakkanukrauhSiraphop SuwannarojWitsarut ManasirisukJitjira ChaiyaritApichat Sangchan

Published in: International journal of rheumatic diseases (2023)

Alginic acid plus PPI does not represent good value for money compared with the standard treatment among such SSc patients in Thailand unless its price is reduced significantly.

Keyphrases

systemic sclerosis
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
rheumatoid arthritis
patient reported outcomes